CCR4 and COVID-19: We noticed that the frequency of CM cells expressing CCR4 increased dependently on the severity at time-point I and further increased at time-point II, exhibiting significant expansion in severe individuals (Figure 3D), whereas activated CM population expressing CD38 and ICOS, even if significantly increased after moderate and severe COVID-19 at 3 months after COVID-19 (time-point I), strongly decreased at longer recovery till 6 months after COVID-19 (time-point II) in all groups (Figure 3D).